Pharmaceuticals, Biotechnology and Life Sciences
Management to host webcast and conference call on October 7 at 8 a.m. ETSAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE)…
The KN-8701 trial is a multi-center, open-label, two-part trial of Kinnate’s lead RAF inhibitor candidate KIN-2787SAN FRANCISCO and SAN DIEGO,…
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the…
Cloud-based and validated regulatory software automates and advances quality of patient narrativesPRINCETON, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) — Certara,…
PHILADELPHIA, Sept. 30, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC),…
NEW HAVEN, Conn., Sept. 30, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical…
SAN FRANCISCO, Sept. 30, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D.,…
– Late-breaking oral presentation will feature a comprehensive review of 58-week results from the company’s Phase 2 PaTH Forward Trial –…
HANGZHOU, China, Sept. 30, 2021 (GLOBE NEWSWIRE) — Hangzhou Chance Pharmaceuticals (“Chance”), a clinical-stage biotechnology company focusing on discovering, developing,…
VANCOUVER, British Columbia, Sept. 29, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower…